CDK4/6 inhibition sensitizes myeloma to lenalidomide by reducing the MEIS2 to CRBN ratio that accelerates IKZF1 and IKZF3 degradation

ABSTRACT: The RNA-seq data presented in this study include libraries from bone marrow plasma cells (BMPC), primary myeloma cells (BMMCs) from 7 patients, and myeloma cell line MM1.S and KMS12

ORGANISM(S): Homo sapiens

PROVIDER: GSE76425 | GEO | 2018/12/28

REPOSITORIES: GEO